Canada Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End-use (Medical, Recreational, Industrial), And Segment Forecasts, 2024 - 2030

Canada Legal Cannabis Market Size, Share & Trends Analysis Report By Source (Marijuana, Hemp), By Derivatives (CBD, THC), By Cultivation, By End-use (Medical, Recreational, Industrial), And Segment Forecasts, 2024 - 2030


Canada Legal Cannabis Market Growth & Trends

The Canada legal cannabis market size is expected to reach USD 5.79 billion by 2030, registering a CAGR of 10.1% from 2024 to 2030, according to a new report by Grand View Research, Inc. Growing awareness of the health benefits related to cannabis and CBD consumption for treating anxiety & seizures and reducing pain is projected to propel the market growth. The high demand for CBD for health and wellness purposes, attributed to its therapeutic properties, is a key driver in the market's growth.

Moreover, the rising number of clinical trials signifies the positive effects of utilizing cannabis for treating various medical conditions. For instance, in February 2024, researchers at the University of British Columbia introduced a first-of-its-kind clinical trial examining the potential of CBD as a treatment for bipolar depression. The trials were approved by Health Canada and funded by the Canadian Institutes of Health Research (CIHR) to investigate how CBD can help manage acute bipolar depression.

Moreover, medical professionals' increasing preference for cannabinoid-based formulations to treat numerous health conditions is another major factor supporting the country's market. Healthcare professionals' higher preference for CBG, CBN-derived products creates a positive influence on consumer minds, thereby boosting their adoption rate and popularity. For instance, in October 2021, Cronos Group Inc. launched its SPINACH FEELZ Chill Bliss 2:1 THC|CBG gummy that features THC and cultured CBG.

Some of the key players in the market are Canopy Growth Corporation, Charlotte's Web, Inc., Aurora Cannabis, Tilray Brands, The Cronos Group, Jazz Pharmaceuticals, Inc., Sundial Growers, and Maricann, Inc. These market players adopt key strategic initiatives to expand their business footprint and market position. For instance, in April 2023, Aurora Cannabis Inc. partnered with Strainprint and announced the launch of the tracking program through Strainprint App. The tracking program is designed for Aurora patients to keep track of their medical cannabis journey.

Furthermore, the rise in awareness regarding cannabis and its potential use in various industries and the introduction of educational programs boost the market growth. For instance, in July 2022, Tilray Brands launched a cannabis education platform, WeCare-Medical Cannabis. The platform is dedicated to educating patients and healthcare practitioners about medical cannabis.

Canada Legal Cannabis Market Report Highlights
  • Based on source, the marijuana segment dominated the market in 2023 and is anticipated to witness the fastest growth over the forecast period owing to the growing adoption of marijuana-based products
  • Based on derivatives, the CBD segment held the largest market share in 2023, owing to the awareness regarding CBD's effectiveness in treating various medical conditions
  • Based on cultivation, the indoor segment held the largest market share in 2023 due to the incorporation of artificial intelligence (AI) in cannabis cultivation, rising investments, and favorable government initiatives
  • Based on end use, the recreational segment dominated the market in 2023 and is anticipated to grow at the fastest CAGR over the forecast period due to the growing consumption of cannabis in the form of vapes, foods, and beverages
Please note The report will be delivered in 2-3 business days upon order notification.


Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Segment scope
1.1.2. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.4.1. Data analysis models
1.5. Market Formulation & Validation
1.6. Model Details
1.6.1. Commodity flow analysis (Model 1)
1.6.1.1. Approach 1: Commodity flow approach
1.7. Research Assumptions
1.8. List of Secondary Sources
1.9. List of Primary Sources
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Source outlook
2.2.2. Derivatives outlook
2.2.3. Cultivation outlook
2.2.4. End Use outlook
2.3. Competitive Insights
Chapter 3. Canada Legal Cannabis Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Ancillary market outlook
3.2. Market Dynamics
3.2.1. Market driver analysis
3.2.2. Market restraint analysis
3.3. Canada Legal Cannabis: Market Analysis Tools
3.3.1. Industry Analysis - Porter’s
3.3.2. PESTLE Analysis
3.4. Regulatory Framework
Chapter 4. Canada Legal Cannabis Market Segment Analysis, By Source, 2018 - 2030 (USD Million)
4.1. Definition and Scope
4.2. Product Market Share Analysis, 2023 & 2030
4.3. Segment Dashboard
4.4. Canada Legal Cannabis market, by Source, 2018 to 2030
4.5. Marijuana
4.5.1. Marijuana market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.2. Flowers
4.5.2.1. Flowers market estimates and forecasts, 2018 to 2030 (USD Million)
4.5.3. Oil and Tinctures
4.5.3.1. Oil and Tinctures market estimates and forecasts, 2018 to 2030 (USD Million)
4.6. Hemp
4.6.1. Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.2. Hemp Oil
4.6.2.1. Hemp Oil market estimates and forecasts, 2018 to 2030 (USD Million)
4.6.3. Industrial Hemp
4.6.3.1. Industrial Hemp market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Canada Legal Cannabis Market Segment Analysis, By Derivatives, 2018 - 2030 (USD Million)
5.1. Definition and Scope
5.2. Derivatives Market Share Analysis, 2023 & 2030
5.3. Segment Dashboard
5.4. Canada Legal Cannabis market, by Derivatives, 2018 to 2030
5.5. CBD
5.5.1. CBD market estimates and forecasts, 2018 to 2030 (USD Million)
5.6. THC
5.6.1. THC market estimates and forecasts, 2018 to 2030 (USD Million)
5.7. Other derivatives
5.7.1. Other derivatives market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Canada Legal Cannabis Market Segment Analysis, By Cultivation, 2018 - 2030 (USD Million)
6.1. Definition and Scope
6.2. Cultivation Market Share Analysis, 2023 & 2030
6.3. Segment Dashboard
6.4. Canada Legal Cannabis market, by Cultivation, 2018 to 2030
6.5. Indoor Cultivation
6.5.1. Indoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.6. Greenhouse Cultivation
6.6.1. Greenhouse Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
6.7. Outdoor Cultivation
6.7.1. Outdoor Cultivation market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Canada Legal Cannabis Market Segment Analysis, By End Use, 2018 - 2030 (USD Million)
7.1. Definition and Scope
7.2. End Use Market Share Analysis, 2023 & 2030
7.3. Segment Dashboard
7.4. Global Canada Legal Cannabis Market, by End Use, 2018 to 2030
7.5. Medical Use
7.5.1. Medical Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.2. Cancer
7.5.2.1. Cancer Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.3. Chronic Pain
7.5.3.1. Chronic Pain Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.4. Depression and Anxiety
7.5.4.1. Depression and Anxiety Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.5. Arthritis
7.5.5.1. Arthritis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.6. Diabetes
7.5.6.1. Diabetes Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.7. Glaucoma
7.5.7.1. Glaucoma Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.8. Migraine
7.5.8.1. Migraine Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.9. Epilepsy
7.5.9.1. Epilepsy Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.10. Multiple Sclerosis
7.5.10.1. Multiple Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.11. AIDS
7.5.11.1. AIDS Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.12. Amyotrophic Lateral Sclerosis
7.5.12.1. Amyotrophic Lateral Sclerosis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.13. Alzheimer’s
7.5.13.1. Alzheimer’s Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.14. Post Traumatic Stress Disorder (PTSD)
7.5.14.1. Post Traumatic Stress Disorder (PTSD) Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.15. Parkinson's
7.5.15.1. Parkinson's Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.16. Tourette’s
7.5.16.1. Tourette’s Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5.17. Others
7.5.17.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Recreational Use
7.6.1. Recreational Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
7.7. Industrial Use
7.7.1. Industrial Use Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
Chapter 8. Competitive Landscape
8.1. Recent Developments & Impact Analysis, By Key Market Participants
8.2. Company Categorization
8.3. Company Profiles
8.3.1. Canopy Growth Corporation
8.3.1.1. Company overview
8.3.1.2. Financial performance
8.3.1.3. Product benchmarking
8.3.1.4. Strategic initiatives
8.3.2. Charlotte's Web, Inc.
8.3.2.1. Company overview
8.3.2.2. Financial performance
8.3.2.3. Product benchmarking
8.3.2.4. Strategic initiatives
8.3.3. Aurora Cannabis Inc.
8.3.3.1. Company overview
8.3.3.2. Financial performance
8.3.3.3. Product benchmarking
8.3.3.4. Strategic initiatives
8.3.4. Tilray Brands
8.3.4.1. Company overview
8.3.4.2. Financial performance
8.3.4.3. Product benchmarking
8.3.4.4. Strategic initiatives
8.3.5. The Cronos Group
8.3.5.1. Company overview
8.3.5.2. Financial performance
8.3.5.3. Product benchmarking
8.3.5.4. Strategic initiatives
8.3.6. Jazz Pharmaceuticals, Inc.
8.3.6.1. Company overview
8.3.6.2. Financial performance
8.3.6.3. Product benchmarking
8.3.6.4. Strategic initiatives
8.3.7. Sundial Growers
8.3.7.1. Company overview
8.3.7.2. Financial performance
8.3.7.3. Product benchmarking
8.3.7.4. Strategic initiatives
8.3.8. Organigram Holding, Inc.
8.3.8.1. Company overview
8.3.8.2. Financial performance
8.3.8.3. Product benchmarking
8.3.8.4. Strategic initiatives
8.3.9. Maricann, Inc.
8.3.9.1. Company overview
8.3.9.2. Financial performance
8.3.9.3. Product benchmarking
8.3.9.4. Strategic initiatives
8.3.10. Isodiol International, Inc
8.3.10.1. Company overview
8.3.10.2. Financial performance
8.3.10.3. Product benchmarking
8.3.10.4. Strategic initiatives

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings